US4954487A
(en)
*
|
1979-01-08 |
1990-09-04 |
The Procter & Gamble Company |
Penetrating topical pharmaceutical compositions
|
CA1179271A
(fr)
*
|
1981-10-23 |
1984-12-11 |
Jean-Francois Grollier |
Composition epaissie anhydre, stable a l'oxydation, a base d'anthraline ou de l'un de ses derives dans un support constitue d'un alkyl ester d'acide gras et d'un agent epaississant, et son utilisation dans le traitement des maladies de la peau
|
FR2520233A1
(fr)
*
|
1982-01-28 |
1983-07-29 |
Oreal |
Composition d'anthraline ou de l'un de ses derives dans un ester aromatique et son utilisation dans le traitement des maladies de la peau
|
US4552872A
(en)
*
|
1983-06-21 |
1985-11-12 |
The Procter & Gamble Company |
Penetrating topical pharmaceutical compositions containing corticosteroids
|
US4537776A
(en)
*
|
1983-06-21 |
1985-08-27 |
The Procter & Gamble Company |
Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
|
US4557934A
(en)
|
1983-06-21 |
1985-12-10 |
The Procter & Gamble Company |
Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
|
LU85111A1
(fr)
*
|
1983-12-01 |
1985-09-12 |
Oreal |
Composition anti-acnetique a base de peroxyde de benzoyle et d'au moins un filtre solaire
|
US4672076A
(en)
*
|
1984-04-27 |
1987-06-09 |
Warner-Lambert Company |
Non-steroidal anti-inflammatory compounds and compositions thereof
|
US4626539A
(en)
*
|
1984-08-10 |
1986-12-02 |
E. I. Dupont De Nemours And Company |
Trandermal delivery of opioids
|
US4568343A
(en)
*
|
1984-10-09 |
1986-02-04 |
Alza Corporation |
Skin permeation enhancer compositions
|
US5446028A
(en)
*
|
1985-12-12 |
1995-08-29 |
Dermik Laboratories, Inc. |
Anti-acne method and composition
|
US4713394A
(en)
*
|
1986-01-17 |
1987-12-15 |
Thornfeldt Carl R |
Treatment of nonacne inflammatory and infectious dermatoses and hair loss
|
US5208257A
(en)
*
|
1986-04-21 |
1993-05-04 |
Kabara Jon J |
Topical antimicrobial pharmaceutical compositions and methods
|
CA1331559C
(en)
*
|
1986-04-21 |
1994-08-23 |
Jon Joseph Kabara |
Antimicrobial preservative compositions and methods
|
US5041439A
(en)
*
|
1986-06-13 |
1991-08-20 |
The Procter & Gamble Company |
Penetrating topical pharmaceutical compositions
|
US5196410A
(en)
*
|
1986-10-31 |
1993-03-23 |
Pfizer Inc. |
Transdermal flux enhancing compositions
|
US4746515A
(en)
*
|
1987-02-26 |
1988-05-24 |
Alza Corporation |
Skin permeation enhancer compositions using glycerol monolaurate
|
US4788062A
(en)
*
|
1987-02-26 |
1988-11-29 |
Alza Corporation |
Transdermal administration of progesterone, estradiol esters, and mixtures thereof
|
US4940586A
(en)
*
|
1987-02-26 |
1990-07-10 |
Alza Corporation |
Skin permeation enhancer compositions using sucrose esters
|
US4865848A
(en)
*
|
1987-02-26 |
1989-09-12 |
Alza Corporation |
Skin permeation enhancer compositions using sucrose esters
|
LU86945A1
(fr)
*
|
1987-07-17 |
1989-03-08 |
Oreal |
Compositions pharmaceutiques et cosmetiques a base de pyridones et d'agents antibacteriens
|
US4764379A
(en)
*
|
1987-08-24 |
1988-08-16 |
Alza Corporation |
Transdermal drug delivery device with dual permeation enhancers
|
US4820720A
(en)
*
|
1987-08-24 |
1989-04-11 |
Alza Corporation |
Transdermal drug composition with dual permeation enhancers
|
US5196416A
(en)
*
|
1987-08-28 |
1993-03-23 |
Eli Lilly And Company |
Transdermal flux-enhancing pharmaceutical compositions comprising azone, ethanol and water
|
US4863738A
(en)
*
|
1987-11-23 |
1989-09-05 |
Alza Corporation |
Skin permeation enhancer compositions using glycerol monooleate
|
US4906475A
(en)
*
|
1988-02-16 |
1990-03-06 |
Paco Pharmaceutical Services |
Estradiol transdermal delivery system
|
US5378730A
(en)
*
|
1988-06-09 |
1995-01-03 |
Alza Corporation |
Permeation enhancer comprising ethanol and monoglycerides
|
US5641504A
(en)
*
|
1988-06-09 |
1997-06-24 |
Alza Corporation |
Skin permeation enhancer compositions using glycerol monolinoleate
|
US5026556A
(en)
*
|
1988-11-10 |
1991-06-25 |
Norwich Eaton Pharmaceuticals, Inc. |
Compositions for the transdermal delivery of pharmaceutical actives
|
US6028105A
(en)
*
|
1989-04-06 |
2000-02-22 |
Nigra; Thomas P. |
Topical drug delivery composition and method
|
JPH0383924A
(ja)
*
|
1989-08-28 |
1991-04-09 |
Kanebo Ltd |
経皮投与用組成物
|
DK0416804T3
(da)
*
|
1989-09-04 |
1993-06-21 |
Yamanouchi Pharma Co Ltd |
Præparat til udvortes administration
|
US5219877A
(en)
*
|
1989-09-25 |
1993-06-15 |
Bristol-Myers Squibb Company |
Lauryl alcohol as skin penetration enhancer for topical imidazole agents
|
DE4115849A1
(de)
*
|
1991-05-15 |
1992-11-19 |
Lohmann Therapie Syst Lts |
Penetrationsfoerdernde substanz
|
GB9201639D0
(en)
*
|
1992-01-25 |
1992-03-11 |
Smithkline Beecham Plc |
Pharmaceutical formulations
|
DE69326848T2
(de)
*
|
1992-05-13 |
2000-01-27 |
Alza Corp |
Oxybutynin zur transdermalen Verabreichung
|
US5900250A
(en)
*
|
1992-05-13 |
1999-05-04 |
Alza Corporation |
Monoglyceride/lactate ester permeation enhancer for oxybutnin
|
JP2937667B2
(ja)
*
|
1992-11-19 |
1999-08-23 |
高砂香料工業株式会社 |
尋常性ざ瘡用皮膚外用剤
|
US5451407A
(en)
*
|
1993-06-21 |
1995-09-19 |
Alza Corporation |
Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug
|
AU7396294A
(en)
*
|
1993-06-25 |
1995-01-24 |
Alza Corporation |
Incorporating poly-n-vinyl amide in a transdermal system
|
US5391367A
(en)
*
|
1993-07-28 |
1995-02-21 |
Pfizer Inc. |
Antifungal nail solution
|
US5916545A
(en)
*
|
1993-07-28 |
1999-06-29 |
Pfizer Inc. |
Antifungal nail solution
|
WO1995009007A1
(en)
*
|
1993-09-29 |
1995-04-06 |
Alza Corporation |
Monoglyceride/lactate ester permeation enhancer for oxybutynin
|
DE4334553C2
(de)
*
|
1993-10-11 |
1998-05-20 |
Synopharm Gmbh Pharmazeutische |
Flüssiges pharmazeutisches System zur perkutanen Applikation
|
CN100335063C
(zh)
|
1994-10-26 |
2007-09-05 |
诺瓦蒂斯有限公司 |
药物组合物
|
GB2327610B
(en)
*
|
1994-11-04 |
1999-06-02 |
Novartis Ag |
Macrolide compositions
|
US5616337A
(en)
*
|
1995-01-30 |
1997-04-01 |
Genta Incorporated |
Unit dose skin care package
|
US5785991A
(en)
*
|
1995-06-07 |
1998-07-28 |
Alza Corporation |
Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
|
AUPN814496A0
(en)
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
US6923983B2
(en)
|
1996-02-19 |
2005-08-02 |
Acrux Dds Pty Ltd |
Transdermal delivery of hormones
|
US6916487B2
(en)
*
|
1996-02-19 |
2005-07-12 |
Acrux Dds Pty Ltd |
Transdermal delivery of antiemetics
|
US6998138B2
(en)
*
|
1996-02-19 |
2006-02-14 |
Acrux Dds Pty. Ltd. |
Topical delivery of anti-alopecia agents
|
US6916486B2
(en)
*
|
1996-02-19 |
2005-07-12 |
Acrux Dds Pty Ltd |
Transdermal delivery of analgesics
|
US7094422B2
(en)
*
|
1996-02-19 |
2006-08-22 |
Acrux Dds Pty Ltd. |
Topical delivery of antifungal agents
|
US6929801B2
(en)
*
|
1996-02-19 |
2005-08-16 |
Acrux Dds Pty Ltd |
Transdermal delivery of antiparkinson agents
|
US5929086A
(en)
*
|
1996-05-10 |
1999-07-27 |
Pharmacia & Upjohn Company |
Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases
|
US6221847B1
(en)
|
1996-09-13 |
2001-04-24 |
Clemson University |
Composition and method for treating bacterial infection
|
WO1998010743A1
(en)
*
|
1996-09-13 |
1998-03-19 |
Clemson University |
Composition for treating acne
|
DK0934078T3
(da)
*
|
1996-10-24 |
2003-04-14 |
Alza Corp |
Permeabilitetsfremmere til transdermal administrering af aktivstoffer, anordninger og fremgangsmåde til fremstilling deraf
|
KR20000053244A
(ko)
|
1996-11-12 |
2000-08-25 |
도브 타마킨 |
피부질환의 치료방법
|
CZ295797B6
(cs)
*
|
1997-04-04 |
2005-11-16 |
Bochemie, S.R.O. |
Sloučeniny na bázi derivátů omega-aminokyselin, způsob jejich výroby a jejich použití
|
GB9723669D0
(en)
|
1997-11-07 |
1998-01-07 |
Univ Aberdeen |
Skin penetration enhancing components
|
US6267984B1
(en)
|
1997-12-22 |
2001-07-31 |
Alza Corporation |
Skin permeation enhancer compositions comprising a monoglyceride and ethyl palmitate
|
US6013637A
(en)
*
|
1998-06-12 |
2000-01-11 |
Dermik Laboratories Inc. |
Anti-acne method and composition
|
US6120756A
(en)
*
|
1998-08-19 |
2000-09-19 |
Philip I. Markowitz |
Topical anionic salicylate for disorders of the skin
|
DE19917548A1
(de)
*
|
1999-04-19 |
2000-10-26 |
August Wolff Gmbh & Co Arzneim |
Pharmazeutische Zusammensetzung auf der Basis von Erythromycin-Fettsäuresalzen mit 12 bis 22 Kohlenstoffatomen im Fettsäurerest und Verwendung dieser Erythromycin-Fettsäuresalze zur topischen Behandlung von Hauterkrankungen
|
FR2794023B1
(fr)
*
|
1999-05-28 |
2003-04-25 |
Codif Internat Sa |
Composition cosmetique destinee a renforcer l'efficacite des principes actifs d'autres compositions cosmetiques
|
US6544541B1
(en)
|
1999-06-02 |
2003-04-08 |
Cardiovascular Solutions, Inc. |
Devices and compounds for treating arterial restenosis
|
WO2001050860A1
(en)
*
|
2000-01-13 |
2001-07-19 |
Medicis Pharmaceutical Corporation |
Improved topical drug delivery composition and method
|
MXPA02008072A
(es)
*
|
2000-02-16 |
2004-04-05 |
Bentley Pharmaceuticals Inc |
Composicion farmaceutica.
|
US7179483B2
(en)
|
2000-04-26 |
2007-02-20 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
US8512718B2
(en)
|
2000-07-03 |
2013-08-20 |
Foamix Ltd. |
Pharmaceutical composition for topical application
|
US6503894B1
(en)
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
JP2002284705A
(ja)
*
|
2001-01-19 |
2002-10-03 |
Shiseido Co Ltd |
刺激緩和剤
|
US20090162342A1
(en)
*
|
2001-06-07 |
2009-06-25 |
Sanomune Inc. |
Therapeutic uses of glandular kallikrein
|
US20050037030A1
(en)
*
|
2001-12-13 |
2005-02-17 |
Mukesh Kumar |
Stable topical formulation of clarithromycin
|
US7641919B2
(en)
*
|
2001-12-28 |
2010-01-05 |
Inter American University Of Puerto Rico |
Anti-bacterial plant compositions
|
US7887860B2
(en)
*
|
2001-12-28 |
2011-02-15 |
Inter American University Of Puerto Rico |
Anti-bacterial plant compositions
|
DE60142189D1
(de)
*
|
2001-12-28 |
2010-07-01 |
Inter American University Of P |
Antibakterielle extrakte aus mammea americana
|
US20040033253A1
(en)
*
|
2002-02-19 |
2004-02-19 |
Ihor Shevchuk |
Acyl opioid antagonists
|
EP2298302A1
(de)
*
|
2002-06-10 |
2011-03-23 |
Euro-Celtique S.A. |
Entsorgungssysteme transdermaler Freisetzungsvorrichtungen zum Schutz vor Missbrauch der darin enthaltenen Wirkstoffe
|
EP1530469B1
(de)
*
|
2002-08-20 |
2009-02-25 |
Euro-Celtique S.A. |
Transdermale dosierungsform enthaltend einen wirkstoff und einen antagonisten in freier base und in salz form
|
IL152486A0
(en)
|
2002-10-25 |
2003-05-29 |
Meir Eini |
Alcohol-free cosmetic and pharmaceutical foam carrier
|
US20080138296A1
(en)
|
2002-10-25 |
2008-06-12 |
Foamix Ltd. |
Foam prepared from nanoemulsions and uses
|
US9265725B2
(en)
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
US10117812B2
(en)
|
2002-10-25 |
2018-11-06 |
Foamix Pharmaceuticals Ltd. |
Foamable composition combining a polar solvent and a hydrophobic carrier
|
US7704518B2
(en)
|
2003-08-04 |
2010-04-27 |
Foamix, Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
MXPA05004278A
(es)
|
2002-10-25 |
2005-10-05 |
Foamix Ltd |
Espuma cosmetica y farmaceutica.
|
US8900554B2
(en)
|
2002-10-25 |
2014-12-02 |
Foamix Pharmaceuticals Ltd. |
Foamable composition and uses thereof
|
US8119109B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Foamable compositions, kits and methods for hyperhidrosis
|
US9668972B2
(en)
|
2002-10-25 |
2017-06-06 |
Foamix Pharmaceuticals Ltd. |
Nonsteroidal immunomodulating kit and composition and uses thereof
|
US8486376B2
(en)
|
2002-10-25 |
2013-07-16 |
Foamix Ltd. |
Moisturizing foam containing lanolin
|
US7820145B2
(en)
|
2003-08-04 |
2010-10-26 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
US7700076B2
(en)
|
2002-10-25 |
2010-04-20 |
Foamix, Ltd. |
Penetrating pharmaceutical foam
|
US9211259B2
(en)
|
2002-11-29 |
2015-12-15 |
Foamix Pharmaceuticals Ltd. |
Antibiotic kit and composition and uses thereof
|
US8119150B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Non-flammable insecticide composition and uses thereof
|
US20040138104A1
(en)
*
|
2003-01-14 |
2004-07-15 |
The Government Of The United States Of America Represented By The Secretary, |
Peptides
|
US7575739B2
(en)
|
2003-04-28 |
2009-08-18 |
Foamix Ltd. |
Foamable iodine composition
|
US8795693B2
(en)
|
2003-08-04 |
2014-08-05 |
Foamix Ltd. |
Compositions with modulating agents
|
US8486374B2
(en)
|
2003-08-04 |
2013-07-16 |
Foamix Ltd. |
Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
|
US20080020028A1
(en)
*
|
2003-08-20 |
2008-01-24 |
Euro-Celtique S.A. |
Transdermal dosage form comprising an active agent and a salt and a free-base form of an adverse agent
|
US20070031462A1
(en)
*
|
2003-12-02 |
2007-02-08 |
Blotsky Roger D |
Powder exfoliating compositions and methods for producing the same
|
US20070190173A1
(en)
*
|
2003-12-02 |
2007-08-16 |
Blotsky Roger D |
Antioxidant skin compositions and methods of production of the same
|
US8709497B2
(en)
|
2003-12-02 |
2014-04-29 |
Roger D. Blotsky |
Mineral, nutritional, cosmetic, pharmaceutical, and agricultural compositions and methods for producing the same
|
US7105263B2
(en)
*
|
2003-12-30 |
2006-09-12 |
Samsung Electronics Company |
Dry toner comprising encapsulated pigment, methods and uses
|
US20060008432A1
(en)
*
|
2004-07-07 |
2006-01-12 |
Sebastiano Scarampi |
Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
|
USRE46558E1
(en)
|
2005-04-28 |
2017-09-26 |
Paloma Pharmaceuticals, Inc. |
Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
|
US20060257337A1
(en)
*
|
2005-04-28 |
2006-11-16 |
David Sherris |
Compositions and methods to treat skin diseases characterized by cellular proliferation and angiogenesis
|
JP5584415B2
(ja)
|
2005-10-12 |
2014-09-03 |
ユニメッド・ファーマシューティカルズ・エルエルシー |
改良したテストステロンゲル製剤及び使用の方法
|
WO2007117352A2
(en)
*
|
2006-02-08 |
2007-10-18 |
Howard Murad |
Topical therapeutic delivery system
|
MX2008011013A
(es)
*
|
2006-02-28 |
2008-10-23 |
Paloma Pharmaceuticals Inc |
Composiciones y metodos para tratar enfermedades caracterizadas por proliferacion celular y angiogenesis.
|
US20080260655A1
(en)
|
2006-11-14 |
2008-10-23 |
Dov Tamarkin |
Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
US8927031B2
(en)
|
2007-10-10 |
2015-01-06 |
Core Intellectual Properties Holdings, Llc |
Anti-glycation methods and compositions
|
US9439857B2
(en)
|
2007-11-30 |
2016-09-13 |
Foamix Pharmaceuticals Ltd. |
Foam containing benzoyl peroxide
|
WO2009072007A2
(en)
|
2007-12-07 |
2009-06-11 |
Foamix Ltd. |
Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
|
WO2010041141A2
(en)
|
2008-10-07 |
2010-04-15 |
Foamix Ltd. |
Oil-based foamable carriers and formulations
|
CA2712120A1
(en)
|
2008-01-14 |
2009-07-23 |
Foamix Ltd. |
Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
|
EP2271334B1
(de)
*
|
2008-03-25 |
2015-08-12 |
Paloma Pharmaceuticals, Inc. |
Verfahren zur behandlung von fibrotischen erkrankungen
|
US20090304776A1
(en)
*
|
2008-06-06 |
2009-12-10 |
Totada Shantha |
Transmucosal delivery of therapeutic agents and methods of use thereof
|
US7883487B2
(en)
*
|
2008-06-16 |
2011-02-08 |
Shantha Totada R |
Transdermal local anesthetic patch with injection port
|
WO2010005521A1
(en)
*
|
2008-06-30 |
2010-01-14 |
Bltn, Llc |
Azelaic acid ester compositions and methods for diagnosing and treating tissue conditions using azelaic acid ester compositions and proteinaceous biomarkers
|
US20100129465A1
(en)
*
|
2008-07-03 |
2010-05-27 |
Roger Blotsky |
Methods and Compositions Related to Acne Treatment
|
US8313782B2
(en)
|
2008-12-18 |
2012-11-20 |
Guthery B Eugene |
Acne vulgaris treatment regimen
|
WO2010125470A2
(en)
|
2009-04-28 |
2010-11-04 |
Foamix Ltd. |
Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
|
WO2011013008A2
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
|
CA2769625C
(en)
|
2009-07-29 |
2017-04-11 |
Foamix Ltd. |
Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
|
CA2776474C
(en)
|
2009-10-02 |
2021-01-12 |
Foamix Ltd. |
Topical tetracycline compositions
|
US9849142B2
(en)
|
2009-10-02 |
2017-12-26 |
Foamix Pharmaceuticals Ltd. |
Methods for accelerated return of skin integrity and for the treatment of impetigo
|
US9180141B1
(en)
|
2010-09-21 |
2015-11-10 |
Core Intellectual Properties Holdings, Llc |
Methods and compositions for animal feed
|
US9381187B2
(en)
|
2011-02-16 |
2016-07-05 |
Paloma Pharmaceuticals, Inc. |
Radiation countermeasure agents
|
ES2583093T3
(es)
|
2011-03-03 |
2016-09-19 |
Denovamed Inc. |
Compuestos antimicrobianos/adyuvantes
|
WO2013173923A1
(en)
|
2012-05-25 |
2013-11-28 |
Diamedica, Inc. |
Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
|
SI2854841T1
(sl)
|
2012-06-04 |
2017-06-30 |
Diamedica Inc. |
Glikozilacijske izooblike humanega tkivnega kalikreina-1
|
MX2020012139A
(es)
|
2016-09-08 |
2021-01-29 |
Vyne Pharmaceuticals Inc |
Composiciones y metodos para tratar rosacea y acne.
|
JP2020510023A
(ja)
|
2017-03-09 |
2020-04-02 |
ダイアメディカ, インコーポレイテッド |
組織カリクレイン1の剤形
|
WO2019169479A1
(en)
|
2018-03-05 |
2019-09-12 |
Denovamed Inc. |
Diphenyl substituted thiophene-2-amide derivatives and pharmaceutical compositions thereof useful as antimicrobial
|
US11311529B2
(en)
*
|
2018-11-08 |
2022-04-26 |
Varsona Therapeutics, Inc. |
Topical formulations of 5-α-reductase inhibitors and uses thereof
|
US11311556B2
(en)
|
2020-05-13 |
2022-04-26 |
Varsona Therapeutics, Inc. |
Topical dutasteride emulsions for treating endocrine therapy-induced alopecia
|